$17.050
-0.198 (-1.16%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Contineum Therapeutics Inc (CTNM) Moving Averages Convergence Divergence (MACD) indicator is 0.67, suggesting CTNM is Strong buy.
Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 15.73, while Contineum Therapeutics Inc (CTNM) share price is $—, making it Buy.
Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 14.40, while Contineum Therapeutics Inc (CTNM) share price is $—, making it Buy.
Technical Analysis for CTNM
AI Technical CTNMAs of 2026-08-29, the technical board for Contineum Therapeutics Inc (CTNM) reads strong buy: 9 indicators are flashing buy, 2 are indicating sell, and 2 are neutral. Price at $17.05 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 62.413, MACD stands at 0.669 (Buy), Stochastic %K stands at 88.172 (Sell), Stochastic %D stands at 86.558 and CCI stands at 116.839 (Sell).
CTNM trades above the 60-day SMA (14.40) and above the 200-day SMA (13.36). Immediate resistance sits at Classic R1 17.84, then R2 19.36. Support sits at Classic S1 14.48, then S2 12.64.
Contineum Therapeutics Inc (CTNM) Support & Resistance Level
Contineum Therapeutics Inc (CTNM) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 62.413 |
| STOCHk_14_3_3 | 88.172 |
| STOCHd_14_3_3 | 86.558 |
| CCI_20 | 116.839 |
| AO_5_34 | 1.819 |
| MOM_10 | 2.860 |
| MACD_12_26_9 | 0.669 |
Contineum Therapeutics Inc (CTNM) Relative Strength Index (RSI_14) is 62.413, creating a Neutral signal.
Contineum Therapeutics Inc (CTNM) Stochastic %K is 88.172, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) Stochastic %D is 86.558, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) CCI_20 is 116.839, creating a Sell signal.
Contineum Therapeutics Inc (CTNM) Awesome Oscillator (AO) is 1.819, creating a Buy signal.
Contineum Therapeutics Inc (CTNM) Momentum (MOM) is 2.860, creating a Buy signal.
Contineum Therapeutics Inc (CTNM) Moving Average Convergence Divergence (MACD) is 0.669, creating a Buy signal.
Contineum Therapeutics Inc (CTNM) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 17.000 | Buy |
| MA_10 | 16.326 | Buy |
| MA_20 | 15.726 | Buy |
| MA_60 | 14.398 | Buy |
| MA_200 | 13.363 | Buy |
| MA_250 | 12.977 | Buy |
Contineum Therapeutics Inc (CTNM) 5-Day simple moving average is 17.000, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 10-Day simple moving average is 16.326, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 15.726, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 14.398, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 200-Day simple moving average is 13.363, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
Contineum Therapeutics Inc (CTNM) 250-Day simple moving average is 12.977, while Contineum Therapeutics Inc (CTNM) share price is $, making it a Buy.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。